skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Could have I an update on your views on Medtronic’s and Qualcomm. Its hold in a RRSP. Would you suggest 1-2 companies for each one with better or same risk profile you would suggest to switch for if you think that’s a good idea .
Read Answer Asked by Olivier on March 17, 2026
Q: Hi,

Already holding HPS.A at 3.6% and I like the growing power thesis. Do you think buying ENS, MPWR or APH would be too much? I like the growth of all these other names but is owning all four too many? How would you rank them to buy now for best risk adjusted return?
Read Answer Asked by Keith on March 17, 2026
Q: between the 2 credit card companies, which is presently the better buy. my metric is present dividend yield compared to
5yr low, 5yr high, 5yr median and
10yr low, 10yr high and 10yr median.
Please provide me those numbers.
Do you have an opinion about a different or more insightful metric to consider?
Read Answer Asked by Ernest on March 17, 2026
Q: For investors already active in US names, would you endorse continuing to hold GLXY into and after the TSX de-listing? Or, for example, do you feel there are more compelling names in the US crypto space to consider for a portfolio?
Read Answer Asked by Andrew on March 17, 2026
Q: Could you give me an update on your view on Starbucks since your last comments 8 months ago. I m holding it in an RRSP account and I am reviewing for maybe a better large cap consumer discretionary stock is you can suggest 2-3 .
Read Answer Asked by Olivier on March 16, 2026
Q: Has been getting a lot of positive news and contract wins. Thoughts on the META deal?

Seems the market is looking at the company as just an AI infrastructure play but they have many other lines of business that is not being taken into account.

I own both names and based on the momentum of NBIS does it make sense to sell IREN and consolidate? This will not impact position size materially of NBIS. Just seems like NBIS is more of a better quality business overall.
Read Answer Asked by Sal on March 16, 2026
Q: Can you comment on the new Nebius / Meta deal please? Is this one of the further contracts that were expected after the Microsoft deal in September? Does it change your outlook for the company? Or is it more of a confirmation. Thanks.
Read Answer Asked by Martin on March 16, 2026
Q: Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots.

Who really knows, what's your opinion on that.

If something like that did happen, which companys would you be investing in now?

Or is it early?

Thank you.
Read Answer Asked by Ross on March 16, 2026
Q: Hi . Looking for your favourite US/International dividend payers is USD. Can you make 5 or 6 suggestions?
Read Answer Asked by Rachel on March 16, 2026
Q: hi folks...thoughts/opinion on Q4 results for Tssi/q...intergration problems of new plant affecting Q3 results, seem to be resolved, and Q4 plus 2026 guidance look pretty good. If Dell is largest customer (Dell member on Tssi Board), what are the chances that Dell would just buy them out. Dan Ives mentioned earlier that he thinks Nebius will be taken out/acquired, thinking the same for Tssi??....would you be comfortable Buying here, or still a Hold...thanks as always, jb
Read Answer Asked by John on March 16, 2026
Q: Hi team,

In attempting to increase the health sector and possibly the international percentage of my portfolio, I am considering the following stocks: ADMA,NHC, QURE,DOCS, CRVS.

Would you recommend any of these or any others for a growth portfolio at this time ?

Gratefully,

Jacques IDS
Read Answer Asked by Jacques on March 16, 2026
Q: From the point of growth in the 2-3 years to come can you tel me the best investment among the three entreprises and why?

Thank you very much in advance
Read Answer Asked by Gabriel on March 13, 2026
Q: You once wrote "The insurance industry tends to perform well in bear markets or stagnant markets (risk-off environments), as they have durable business models with predictable earnings. We like having exposure to the industry as a form of 'insurance' for those unpredictable times when the broader markets soften." My question is around why MMC is performing so poorly, and is this a buying opportunity?
Read Answer Asked by Neil on March 13, 2026
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!